$PETV 8-K/A SEC Filings

PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up units (collectively, the “Units” and individually a “Unit”), each Unit consisting of one (1) share of PetVivo common stock and one (1) common stock purchase w...

Series B Convertible Preferred Stock Offering - $1.00 Per Share

MINNEAPOLIS, MN, US, June 29, 2023, PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, announced it has resche...

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed in the Original Form 8-K, the Company entered into securities purchase agreement and other confirmation of ownership with investors on April 17, 2023 (collectively, the “Purchase Agreements”), pursuant to which th...

This Amended and Restated Securities Purchase Agreement (this “Agreement”) is made as of January 5, 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and each purchaser identified on the signature pages he...

MINNEAPOLIS, MN, US, August 1, 2022 — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and anima...